At a glance
We’re excited to connect with you at this conference.
Meet the Afirma team and learn how Afirma GSC helps guide confident treatment decisions for thyroid nodules.
Featured Presentations & Posters
| Title | Session | Date | Time | Presenter | Location |
|---|
KEAP1 and NFE2L2 Mutations Drive NRF2 Pathway Activation in Indeterminate and Malignant Thyroid Nodules | Poster Session II | Thursday, Nov 5 | 2:45 – 3:45 PM EDT | Taylor Cavazos,
Nicholas Bambach | TBD |
Mrna Analysis of Cell-Surface Protein Targets in Medullary Thyroid Cancer Fine Needle Aspiration Samples | Oral | Thursday, Nov 5 | 5:30 PM – 5:45 PM EDT | Sarah Hamidi | Salon C-D |
Preoperative Transcriptomic Predictors of Benign or Malignant Thyroid Tumors without Expressed Variants and Fusions | Poster Session IV | Friday, Nov 6 | 2:15 – 3:15 PM EDT | Eisha Gupta,
Arti Bhan | TBD |
Preoperative Thyroid Nodule Mrna Expression Signatures to Predict 2025 Ata Risk of Recurrence for Differentiated Thyroid Cancer | Poster Session IV | Friday, Nov 6 | 2:15 – 3:15 PM EDT | Eisha Gupta,
Arti Bhan | TBD |
Prostate-Specific Membrane Antigen (PSMA) mRNA Expression in Thyroid FNA Samples with Bethesda III-VI Cytology Predicts Lymphatic and Angioinvasion in Surgically Resected Tumors | Oral | Friday, Nov 6 | 5:30 – 5:45 PM EDT | Wassim Najjar | Salon C-D |
Meet with us
Interested in connecting with our team at this event? We’d love to hear from you.
Tags
North America
Afirma Thyroid
Afirma GRID